BioLargo Inc (OTCPK:BLGO)

Q4 2025 BioLargo Inc Earnings Call Transcript

Mar 5, 2026 / 05:00 PM GMT

Release Date Price: $0.1695 (-5.60%)

Transcript 10-K

Key Points

Positve

BioLargo Inc (BLGO) has successfully transitioned from development to commercialization across its key technologies, indicating a pivotal shift in its business strategy.
The company has launched Clear Medical commercially and secured an exclusive distribution agreement, providing access to thousands of hospitals and clinics.
BioLargo Inc (BLGO) has advanced critical battery factory partnerships and secured third-party validation of its assembly battery technology.
The company maintains a strong cash position, avoiding toxic debt and ensuring liquidity throughout the year.
BioLargo Inc (BLGO) has a diversified portfolio with four distinct platforms, each targeting large commercial markets, which helps mitigate risks and attract diversified investors.

Negative

BioLargo Inc (BLGO) experienced a decline in revenue to $7.8 million and a loss of $15.2 million in 2025, primarily due to the termination of the Poof licensing agreement.
The company's stockholders' equity declined to $1.5 million, indicating financial challenges.
The termination of the Poof licensing agreement resulted in a significant credit loss of $3.9 million.
Despite the commercial momentum, the company faces challenges in securing new partnerships for its pet products after revoking Poof's license.
BioLargo Inc (BLGO) has not renewed the Lincoln Park Agreement, which could impact its financial stability and access to capital.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

BLGO.PK - BioLargo Inc
Q4 2025 BioLargo Inc Earnings Call
Mar 05, 2026 / 05:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning ladies and gentlemen, and thank you for your patience. Your conference will begin shortly. Once again, thank you for your patience. Your conference will begin shortly.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Good afternoon everyone and thank you for your patience. Welcome to the Biolago 2025 annual report and earnings call.

At this time, all participants have been placed on a listen-only mode, and the floor will be open for questions following the presentation. If anyone should require operator assistance during this conference, please press 0 on your phone keypad.

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.